Results 101 to 110 of about 411,291 (407)

Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials.

JAMA cardiology, 2019
Importance The antithrombotic treatment of patients with atrial fibrillation (AF) and coronary artery disease, in particular with acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI), poses a significant treatment dilemma in ...
R. Lopes, H. Hong, R. Harskamp, Deepak L. Bhatt, R. Mehran, C. Cannon, C. Granger, F. Verheugt, Jianghao Li, J. T. ten Berg, N. Sarafoff, C. Gibson, J. Alexander   +12 more
semanticscholar   +1 more source

Management of Percutaneous Coronary Intervention Complications

Circulation. Cardiovascular Interventions, 2020
Complications of percutaneous coronary intervention (PCI) may have significant impact on patient survival and healthcare costs. PCI procedural complexity and patient risk are increasing, and operators must be prepared to recognize and treat complications,
Jacob A. Doll, Ravi S Hira, Kathleen E. Kearney, D. Kandzari, Robert F. Riley, S. Marso, J. Grantham, C. Thompson, J. McCabe, D. Karmpaliotis, A. Kirtane, W. Lombardi   +11 more
semanticscholar   +1 more source

Increased Thrombogenicity is Associated With Coronary Microvascular Dysfunction in Patients With STEMI—A Proof‐of‐Concept Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Up to 50% of patients with ST‐segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) develop coronary microvascular dysfunction (CMD). Aims This study aims to assess whether a prothrombotic state of coronary blood, defined by thromboelastography (TEG), is associated with post ...
Roberto Scarsini, Denis Leonardi, Andrea Bottardi, Concetta Mammone, Leonardo Portolan, Caterina Butturini, Verdiana Galli, Francesco Della Mora, Alessandro Ruzzarin, Sara Pazzi, Anna Piccoli, Simone Fezzi, Domenico Tavella, Gabriele Pesarini, Leonardo Gottin, Flavio Ribichini   +15 more
wiley   +1 more source

Rotablation-Assisted Staged Culottes Bifurcation Stenting of Left Main Chronic Total Occlusion

JACC: Case Reports, 2023
Left main coronary artery chronic total occlusion is an unusual finding discovered on coronary angiography. Historically, coronary artery bypass graft has been the preferred treatment.
Sharad Chandra, MD, DM, Amit Kumar Singh, MD, DM, Ayush Shukla, MD, DM, Gaurav Chaudhary, MD, DM, Sudhanshu Kumar Dwivedi, MD, DM, Abhishek Singh, MD, DM, Akhil Sharma, MD, DM, Shubhajeet Roy, MBBS, Vaishali Singh, MBBS   +8 more
doaj  

The First‐in‐Man Technique of Drug Eluting and Perfusion Therapy for Left Main Coronary Artery Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Treating ostial left circumflex artery (LCx) lesions in percutaneous coronary intervention (PCI) for left main disease (LMD) remains a challenge. Despite recent recommendations for the use of drug‐coated balloon (DCB) in this lesion, there are concerns about crossover‐stenting from the left main trunk (LMT) to the left anterior ...
Takayuki Warisawa, Yoshiki Kawai, Takuya Matsumoto, Shingo Sato, Makoto Takeyama, Yuta Nakamura, Susumu Katsushika, Aritomo Katsura, Takahiro Sato, Masashiro Matsushita, Jiro Ando   +10 more
wiley   +1 more source

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

Circulation, 2019
Supplemental Digital Content is available in the text.
P. Urban, R. Mehran, R. Colleran, D. Angiolillo, R. Byrne, D. Capodanno, T. Cuisset, D. Cutlip, P. Eerdmans, J. Eikelboom, A. Farb, C. Gibson, J. Gregson, M. Haude, S. James, Hyo‐Soo Kim, Takeshi Kimura, A. Konishi, J. Laschinger, M. Leon, P. A. Magee, Yoshiaki Mitsutake, D. Mylotte, S. Pocock, M. Price, S. Rao, E. Spitzer, E. Spitzer, N. Stockbridge, M. Valgimigli, O. Varenne, Ute Windhoevel, R. Yeh, M. Krucoff, Mitchell W. Krucoff, M. Morice   +35 more
semanticscholar   +1 more source

Treatment With Phosphodiesterase 5 Inhibitors and Long‐Term Outcomes in Patients Undergoing Coronary Angiography and Cardiac Catheterization

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The effects of phosphodiesterase 5 (PDE5) inhibitors on the incidence of long‐term outcomes in patients with cardiovascular disease are not well understood. Objective: We studied the association between PDE5 inhibitor therapy and the incidence of adverse cardiovascular major adverse cardiovascular events (MACE) in patients ...
Sumon Roy, Annette Min, Edward O. McFalls, Robert A. Perera, Fadi N. Salloum, Ion S. Jovin   +5 more
wiley   +1 more source

Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled trials [PDF]

, 2015
Background: Adenosine administered as an adjunct to reperfusion can reduce coronary no-reflow and limit myocardial infarct (MI) size in ST-segment elevation myocardial infarction (STEMI) patients. Whether adjunctive adenosine therapy can improve clinical
Bulluck, Heerajnarain, Garcia-Dorado, David, Hausenloy, Derek J., Loke, Yoon K., Sirker, Alex, Universitat Autònoma de Barcelona   +5 more
core   +2 more sources

Platelet Inhibition in Percutaneous Coronary Interventions [PDF]

Herz Kardiovaskuläre Erkrankungen, 2005
Mechanical disruption of atherosclerotic plaques at the time of percutaneous coronary intervention (PCI) is a potent stimulus for arterial thrombosis. Since platelets play a crucial role in the cascade of clot formation, platelet inhibition is an essential step for successful PCI.
Wyss, Christophe A, Roffi, Marco
openaire   +5 more sources

Propensity Matched Analysis of 14 French Suture‐ Versus Plug‐Based Vascular Closure During Transfemoral Transcatheter Aortic Valve Replacement (TAVR)

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Plug‐based vascular closure devices (Pb‐VCD) and suture‐based vascular closure devices (Sb‐VCD) are used for percutaneous vascular access site closure during transcatheter aortic valve replacement (TAVR). Until now, no clear superiority of either device was shown in studies comparing 18 F VCDs solely.
Tobias Lerchner, Lars Michel, Klaus Tiroch, Tienush Rassaf, Markus Krane, Marc Michael Vorpahl, Hendrik Ruge   +6 more
wiley   +1 more source